The Ian King Business Podcast cover image

The Ian King Business Podcast

Microsoft, weight loss drug sales, and GSK profits surge

Jan 31, 2024
08:30
In today's episode, Ian King speaks with Dan Ives - managing director of the brokerage and advisory firm Wedbush Securities - to discuss Microsoft's revenues and AI.

Ian Johnston, global pharmaceutical correspondent at the Financial Times, discuses sales of popular weight loss drug 'Wegvoy', made by Novo Nordisk - as they say their sales almost quadrupled last year.

And, Ian discusses GSK's operating profit of £8.8billion for 2023 with strong selling medicines including its HIV and shingles medication.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode